M
Marilena Durazzo
Researcher at University of Turin
Publications - 143
Citations - 5607
Marilena Durazzo is an academic researcher from University of Turin. The author has contributed to research in topics: Population & Hepatitis. The author has an hindex of 36, co-authored 130 publications receiving 4953 citations. Previous affiliations of Marilena Durazzo include Hochschule Hannover.
Papers
More filters
Journal ArticleDOI
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis
Giovanni Musso,Roberto Gambino,Franco De Michieli,Maurizio Cassader,Mario Rizzetto,Marilena Durazzo,Emanuela Fagà,Barbara Silli,Gianfranco Pagano +8 more
TL;DR: Dietary habits may promote steatohepatitis directly by modulating hepatic triglyceride accumulation and antioxidant activity as well as indirectly by affecting insulin sensitivity and postprandial triglyceride metabolism.
Journal ArticleDOI
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections
Antonio Bertoletti,Mario Milco D'Elios,Carolina Boni,M De Carli,Anna Linda Zignego,Marilena Durazzo,Gabriele Missale,Amalia Penna,Franco Fiaccadori,G Del Prete,Carlo Ferrari +10 more
TL;DR: The different cytokine profiles of T cells within the liver in chronic HBV and HCV infections illustrate a different behavior of the local immune response in these two infections that may have pathogenetic implications.
Journal ArticleDOI
Adipokines in NASH : Postprandial lipid metabolism as a link between adiponectin and liver disease
Giovanni Musso,Roberto Gambino,Marilena Durazzo,Giampaolo Biroli,Monica Carello,Einanuela Faga,Giovanni Pacini,Franco De Michieli,Laura Rabbione,A. Premoli,Maurizio Cassader,Gianfranco Pagano +11 more
TL;DR: Hypoadiponectinemia is present before overt diabetes and obesity appear and correlates with the severity of liver histology in NASH and may have important pathogenetic and therapeutic implications in both liver and metabolic disease.
Journal ArticleDOI
Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial.
Simona Bo,Giovannino Ciccone,Carla Baldi,Lorenzo Benini,Ferruccio Dusio,Giuseppe Forastiere,Claudio Lucia,Claudio Nuti,Marilena Durazzo,Maurizio Cassader,L. Gentile,Gianfranco Pagano +11 more
TL;DR: A lifestyle intervention based on general recommendations was effective in reducing multiple metabolic/inflammatory abnormalities and the usual care by family physicians was ineffective at modifying progressive metabolic deterioration in high-risk individuals.
Journal ArticleDOI
Hypoadiponectinemia Predicts the Severity of Hepatic Fibrosis and Pancreatic Beta-Cell Dysfunction in Nondiabetic Nonobese Patients with Nonalcoholic Steatohepatitis
Giovanni Musso,Roberto Gambino,Giampaolo Biroli,Monica Carello,Emanuela Fagà,Giovanni Pacini,Franco De Michieli,Maurizio Cassader,Marilena Durazzo,Mario Rizzetto,Gianfranco Pagano +10 more
TL;DR: Hypoadiponectinemia is a feature of NASH and may have a pathogenetic role in β-cell dysfunction and in hepatic necroinflammation and fibrosis, independently of insulin resistance, visceral fat accumulation, TNF-α axis activity, and dietary habits.